# Lantheus Holdings, Inc.: Form 10-Q for the period ended Sep 30, 2019

- Company: [Lantheus Holdings, Inc.](/companies/lnth.md) (CIK 1521036)
- Form: 10-Q
- Filed: 2019-10-31
- Accepted by EDGAR: Oct 31, 2019, 09:18 ET
- Period: 2019-09-30
- Accession: 0001628280-19-012915
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1521036/000162828019012915/lnth10q-093019.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1521036/000162828019012915/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-07-01 to 2019-09-30 | $85.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2019-01-01 to 2019-09-30 | $258.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2019-07-01 to 2019-09-30 | $44.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2019-01-01 to 2019-09-30 | $127.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2019-07-01 to 2019-09-30 | $41.6m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2019-01-01 to 2019-09-30 | $130.2m | us-gaap:GrossProfit |
| Research and development | 3 months, 2019-07-01 to 2019-09-30 | $4.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2019-01-01 to 2019-09-30 | $15.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2019-07-01 to 2019-09-30 | $8.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2019-01-01 to 2019-09-30 | $39.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2019-07-01 to 2019-09-30 | $2.4m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2019-01-01 to 2019-09-30 | $11.5m | us-gaap:InterestExpense |
| Income tax | 3 months, 2019-07-01 to 2019-09-30 | $501.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2019-01-01 to 2019-09-30 | $5.0m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months, 2019-07-01 to 2019-09-30 | $0.12 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2019-01-01 to 2019-09-30 | $0.53 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-07-01 to 2019-09-30 | $0.12 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2019-01-01 to 2019-09-30 | $0.55 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-07-01 to 2019-09-30 | 40,286,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2019-01-01 to 2019-09-30 | 40,123,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2019-01-01 to 2019-09-30 | $58.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2019-01-01 to 2019-09-30 | $17.3m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | at 2019-09-30 | $78.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-09-30 | $154.4m | us-gaap:AssetsCurrent |
| Total assets | at 2019-09-30 | $402.4m | us-gaap:Assets |
| Current liabilities | at 2019-09-30 | $59.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-09-30 | $301.2m | us-gaap:Liabilities |
| Long-term debt | at 2019-09-30 | $186.4m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2019-09-30 | $10.2m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2019-09-30 | $101.2m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1521036/000162828019012915/lnth10q-093019.htm

Filed Oct 31, 2019.
Source: SEC EDGAR, the filing index for accession 0001628280-19-012915. Last ingested by Listed: Nov 13, 2026, 16:20 ET. No prices; not investment advice.
